K. A. Lockman

511 total citations
21 papers, 332 citations indexed

About

K. A. Lockman is a scholar working on Epidemiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, K. A. Lockman has authored 21 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in K. A. Lockman's work include Liver Disease Diagnosis and Treatment (9 papers), Advanced Chemical Sensor Technologies (3 papers) and Emergency and Acute Care Studies (3 papers). K. A. Lockman is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Advanced Chemical Sensor Technologies (3 papers) and Emergency and Acute Care Studies (3 papers). K. A. Lockman collaborates with scholars based in United Kingdom, Netherlands and Australia. K. A. Lockman's co-authors include Joanne C. Graham, Fraser W. Gibb, John Plevris, Peter Hayes, Rohit Sinha, Moffat Nyirenda, Marcus Robertson, Nicholas I. Church, Alan Jaap and Natalie Homer and has published in prestigious journals such as Gut, Journal of Hepatology and Diabetologia.

In The Last Decade

K. A. Lockman

18 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. A. Lockman United Kingdom 8 127 125 99 86 76 21 332
Rajaa Chatila Lebanon 10 107 0.8× 59 0.5× 162 1.6× 25 0.3× 58 0.8× 21 384
Tudor Cuciureanu Romania 10 258 2.0× 76 0.6× 53 0.5× 19 0.2× 153 2.0× 52 361
Shon Meek United States 10 114 0.9× 201 1.6× 147 1.5× 46 0.5× 13 0.2× 21 422
Aysha Aslam United States 10 128 1.0× 38 0.3× 78 0.8× 21 0.2× 46 0.6× 27 302
Giuseppe Baviera Italy 5 359 2.8× 154 1.2× 75 0.8× 45 0.5× 72 0.9× 5 593
Angelo Italia Italy 8 122 1.0× 48 0.4× 128 1.3× 24 0.3× 9 0.1× 23 323
E. Porro Italy 3 290 2.3× 112 0.9× 54 0.5× 24 0.3× 63 0.8× 5 474
Angiola Fontanella Italy 9 317 2.5× 117 0.9× 85 0.9× 48 0.6× 168 2.2× 21 424
Otilia Elena Frăsinariu Romania 9 96 0.8× 49 0.4× 30 0.3× 14 0.2× 21 0.3× 29 276
Pekka Jauhonen Finland 9 149 1.2× 21 0.2× 72 0.7× 84 1.0× 29 0.4× 10 382

Countries citing papers authored by K. A. Lockman

Since Specialization
Citations

This map shows the geographic impact of K. A. Lockman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. A. Lockman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. A. Lockman more than expected).

Fields of papers citing papers by K. A. Lockman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. A. Lockman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. A. Lockman. The network helps show where K. A. Lockman may publish in the future.

Co-authorship network of co-authors of K. A. Lockman

This figure shows the co-authorship network connecting the top 25 collaborators of K. A. Lockman. A scholar is included among the top collaborators of K. A. Lockman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. A. Lockman. K. A. Lockman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sinha, Rohit, Paul Brinkman, K. A. Lockman, et al.. (2022). O24 Unbiased clustering of breath signature in NAFLD identifies disease progression high-risk patient phenotype- 5 year study. Oral Presentations. A13.2–A14. 1 indexed citations
3.
Macpherson, Iain, et al.. (2022). Improving care for patients in the outlying wards: Lessons from patients’ care experience. Acute Medicine Journal. 21(2). 80–85.
4.
Sinha, Rohit, K. A. Lockman, Natalie Homer, et al.. (2020). Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease. JHEP Reports. 2(5). 100137–100137. 27 indexed citations
5.
Murchison, John T., et al.. (2020). Long-Term Outcomes of Patients Investigated for Suspected Upper Extremities Deep Venous Thrombosis Irrespective of Imaging Results. The Journal of the Royal College of Physicians of Edinburgh. 50(1). 19–24.
6.
Lockman, K. A., et al.. (2018). Effective acute care handover to GP: optimising the structure to improve discharge documentation. Acute Medicine Journal. 17(2). 68–76. 2 indexed citations
7.
Sinha, Rahul, K. A. Lockman, Natalie Homer, et al.. (2018). A study of breath metabolome in Non-alcoholic fatty liver disease. Journal of Hepatology. 68. S557–S558.
8.
Sinha, Rahul, et al.. (2017). Carvedilol is associated with improved survival in patients with decompensated cirrhosis. Journal of Hepatology. 66(1). S570–S571. 1 indexed citations
9.
Sinha, Rohit, et al.. (2017). Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites. Journal of Hepatology. 67(1). 40–46. 63 indexed citations
10.
Simpson, J. Michael, et al.. (2016). Excess long-term mortality in outpatient deep venous thrombosis patients managed in an ambulatory care setting. QJM. 110(3). hcw133–hcw133. 1 indexed citations
11.
Gibb, Fraser W., et al.. (2016). Risk of death following admission to a UK hospital with diabetic ketoacidosis. Diabetologia. 59(10). 2082–2087. 109 indexed citations
12.
Sinha, Rohit, K. A. Lockman, Nicholas I. Church, John Plevris, & Peter Hayes. (2016). The use of hemostatic spray as an adjunct to conventional hemostatic measures in high-risk nonvariceal upper GI bleeding (with video). Gastrointestinal Endoscopy. 84(6). 900–906.e3. 30 indexed citations
13.
Lockman, K. A., Rohit Sinha, Leonard J. Nelson, et al.. (2016). Proteomic profiling of cellular steatosis with concomitant oxidative stress in vitro. Lipids in Health and Disease. 15(1). 114–114. 10 indexed citations
14.
Yeung, Emily, Sarah F. Martin, Jonathan Manning, et al.. (2015). Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?. Lipids in Health and Disease. 14(1). 86–86. 14 indexed citations
15.
Lockman, K. A., Karl Burgess, A Pryde, et al.. (2012). PMO-130 Altered acetyl-coa metabolism in hepatic mitochondrial impairment in in vitro models of hepatic cellular steatosis. Gut. 61(Suppl 2). A125.3–A126. 1 indexed citations
16.
Lockman, K. A., et al.. (2011). Comparison of the effects of long-term pioglitazone and rosiglitazone therapy on liver enzymes in type 2 diabetes. The British Journal of Diabetes. 11(3). 121–129. 1 indexed citations
17.
18.
Lockman, K. A. & Moffat Nyirenda. (2010). Interrelationships between Hepatic Fat and Insulin Resistance in Non- Alcoholic Fatty Liver Disease. Current Diabetes Reviews. 6(5). 341–347. 28 indexed citations
19.
Lockman, K. A., et al.. (2008). Multifocal fibrosclerosis: a new case report. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 45(1). 99–101. 3 indexed citations
20.
Lockman, K. A., et al.. (2004). Diabetic MRSA foot infection — role of linezolid therapy. The British Journal of Diabetes. 4(1). 44–46. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajaa Chatila Breakdown of academic impact, for papers by Tudor Cuciureanu Breakdown of academic impact, for papers by Shon Meek Breakdown of academic impact, for papers by Aysha Aslam Breakdown of academic impact, for papers by Giuseppe Baviera Breakdown of academic impact, for papers by Angelo Italia Breakdown of academic impact, for papers by E. Porro Breakdown of academic impact, for papers by Angiola Fontanella Breakdown of academic impact, for papers by Otilia Elena Frăsinariu Breakdown of academic impact, for papers by Pekka Jauhonen
Rankless by CCL
2026